Cabazitaxel (Jevtana®)

Common name: Cabazitaxel
Brand name: Jevtana®
 

What is Cabazitaxel?

Cabazitaxel is a chemotherapy drug used to treat advanced (metastatic) prostate cancer when hormonal therapy is no longer able to control the cancer. Cabazitaxel, used in combination with a corticosteroid (such as prednisone or prednisolone), is often given to men after they have been treated with docetaxel, another chemotherapy drug.
 

How is Cabazitaxel administered?

Cabazitaxel is administered by injection.


What are possible side effects of this treatment?

Everyone responds differently to chemotherapy – some experience many side effects while others experience very few. Below are some side effects experienced by those who received cabazitaxel. Tell your health care team about side-effects you are experiencing so they know how best to help you manage them.
  • Abdominal pain
  • Anemia (low red blood cell count)
  • Bruising / bleeding    
  • Blood in urine (hematuria)
  • Constipation    
  • Diarrhea            
  • Fatigue
  • Infection
  • Kidney problems
  • Loss of appetite
  • Muscle weakness
  • Neutropenia (low white blood cell count)
  • Numbness / tingling in hands and feet

Is Cabazitaxel covered in my province or territory?   

Cabazitaxel is covered by provincial drug programs in:
  • Alberta
  • British Columbia (restricted)
  • Ontario
  • Newfoundland & Labrador
  • Nova Scotia
  • Saskatchewan
Cabazitaxel is not covered by provincial drug programs in:
  • New Brunswick
  • Prince Edward Island
  • Quebec
  • Nunavut
  • Northwest Territories
  • Yukon
Cabazitaxel may be covered by provincial drug programs after individual review in:
  • ​Manitoba​


 
Last Reviewed: July 2017

 



 

Help us take the first steps toward prevention. Donate Now


Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Prostate Cancer Canada launches first national program in radionuclide therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.
More

Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.
More

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.
More


Click here for news archive